
- Oncology NEWS International Vol 11 No 2
- Volume 11
- Issue 2
‘Cancer Prevention Must Move From Thought to Reality’
WASHINGTON-"Cancer prevention now requires that we move from thought to reality," said Carolyn Aldigé, founder and president of the Cancer Research Foundation of America (CRFA). "This mean a new paradigm of the health care system, rather than just taking care of sick people. Treatment of advanced disease has less impact than prevention."
WASHINGTON"Cancer prevention now requires that we move from thought to reality," said Carolyn Aldigé, founder and president of the Cancer Research Foundation of America (CRFA). "This mean a new paradigm of the health care system, rather than just taking care of sick people. Treatment of advanced disease has less impact than prevention."
The Foundation has sponsored the Cancer Prevention Working Group, which has spent 2 years framing the issues and outlining challenges, she said at a meeting of the Working Group. "Now we need to formulate an action plan to take concrete steps. We must engage regulators and the primary care community and convince them that prevention is important," she said.
Ms. Aldigé said that such a plan could be devised within a year, taking the best current practices and research and weaving them into a broad cancer prevention approach.
She called for a summit meeting in the interim to deal with specific issues and barriers, especially questions of approval, regulation, and liability. The keys, she said, are further research to identify chemopreventive agents and devising ways to provide incentives to the pharmaceutical industry.
Articles in this issue
over 23 years ago
R115777 Has Significant Activity in CML and Myelofibrosisover 23 years ago
National Cancer Prevention Campaign Discussedover 23 years ago
CHOP Plus Rituxan Proves Cost-Effective in B-Cell Lymphomaover 23 years ago
Lung Cancer Screening Protocol Moves Forwardover 23 years ago
Cancer Prevention Research Hampered by Lack of Biomarkersover 23 years ago
Rituximab Improves Efficacy of Chemotherapy for Follicular Lymphomasover 23 years ago
Long Survival Confirmed in CML Patients Who Respond to InterferonNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.